SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 92 filers reported holding SPERO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,598 | -83.2% | 17,023 | -79.9% | 0.00% | – |
| Q2 2023 | $122,576 | +163.3% | 84,535 | +163.3% | 0.00% | – |
| Q1 2023 | $46,545 | -32.4% | 32,100 | -19.3% | 0.00% | – |
| Q4 2022 | $68,845 | -78.8% | 39,795 | -90.9% | 0.00% | -100.0% |
| Q2 2022 | $324,000 | -52.8% | 437,280 | +454.2% | 0.00% | -50.0% |
| Q1 2022 | $686,000 | -18.4% | 78,908 | +81.9% | 0.00% | 0.0% |
| Q4 2020 | $841,000 | +120.7% | 43,373 | +54.1% | 0.00% | 0.0% |
| Q2 2020 | $381,000 | +110.5% | 28,150 | +49.5% | 0.00% | +100.0% |
| Q4 2019 | $181,000 | +7.1% | 18,828 | -31.4% | 0.00% | 0.0% |
| Q4 2018 | $169,000 | – | 27,454 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,353,303 | $1,637,497 | 13.93% |
| Anson Funds Management LP | 4,159,572 | $5,033,082 | 1.01% |
| OUP Management Co., LLC | 249,070 | $301,375 | 0.68% |
| Atlas Venture Life Science Advisors, LLC | 1,013,438 | $1,226,260 | 0.19% |
| Murchinson Ltd. | 862,700 | $1,043,867 | 0.13% |
| Alphabet Inc. | 889,979 | $1,076,874 | 0.07% |
| AWM Investment Company, Inc. | 333,400 | $403,414 | 0.06% |
| DAFNA Capital Management LLC | 125,000 | $151,250 | 0.05% |
| Novo Holdings A/S | 468,902 | $567,371 | 0.04% |
| XTX Topco Ltd | 58,368 | $70,625 | 0.01% |